miR-222通过下调DDIT4抑制肾癌细胞自噬

倪晓辰; 赵志红; 马永良

doi:10.3969/j.issn.1007-3969.2015.03.001

您当前的位置：

首页 >

文章列表页 >

miR-222通过下调DDIT4抑制肾癌细胞自噬

更新时间：2025-12-31

- miR-222通过下调DDIT4抑制肾癌细胞自噬
- miR-222 can inhibit the autophagy of renal cell carcinoma cells through down-regulating the expression of DDIT4
- 中国癌症杂志 2015年25卷第3期页码：161-166
- 作者机构：
  
  河北医科大学第四医院泌尿外科,河北,石家庄,050011
- 作者简介：
- 基金信息：
  
  河北省医学科学研究重点课题计划(20110142)。
- DOI：10.3969/j.issn.1007-3969.2015.03.001
  中图分类号：
- 网络出版：2015-05-18，
  
  纸质出版：2015-05-18
- 稿件说明：
移动端阅览
倪晓辰,赵志红,马永良,等. miR-222通过下调DDIT4抑制肾癌细胞自噬[J]. 中国癌症杂志, 2015, 25(3): 161-166.

倪晓辰, 赵志红, 马永良. miR-222 can inhibit the autophagy of renal cell carcinoma cells through down-regulating the expression of DDIT4[J]. China Oncology, 2015, 25(3): 161-166.
倪晓辰,赵志红,马永良,等. miR-222通过下调DDIT4抑制肾癌细胞自噬[J]. 中国癌症杂志, 2015, 25(3): 161-166. DOI： 10.3969/j.issn.1007-3969.2015.03.001.

倪晓辰, 赵志红, 马永良. miR-222 can inhibit the autophagy of renal cell carcinoma cells through down-regulating the expression of DDIT4[J]. China Oncology, 2015, 25(3): 161-166. DOI： 10.3969/j.issn.1007-3969.2015.03.001.

摘要

背景与目的：微小RNA(microRNA，miRNA，miR)在肿瘤的发生、发展中具有重要的作用。miR-222在多种肿瘤组织中表达上调，而其在肾癌(renal cell carcinoma，RCC)中的表达及其作用机制尚不清楚。本研究拟通过检测RCC组织及相应癌旁组织中miR-222的表达情况，探讨miR-222在RCC中的作用。并在体外条件下，通过检测miR-222的下游作用靶点，探讨miR-222的抗RCC作用机制。方法：采用实时定量聚合酶链反应(quantitative real-time polymerase chain reaction，qRT-PCR)检测RCC组织和癌旁组织中miR-222的表达；采用CCK-8法检测细胞的增殖活力；采用蛋白[质]印迹法(Western blot)检测DDIT4蛋白及LC3-Ⅱ的表达；采用荧光素酶实验验证miR-222的作用靶点；转染EGFP-LC3后在激光共聚焦显微镜下观察细胞自噬状态。结果：qRTPCR检测结果显示，miR-222在RCC组织中表达明显上调。在人肾透明细胞癌786-O细胞株中敲低miR-222表达后显著抑制细胞的增殖活力，而过表达miR-222可增强786-O细胞的增殖活力(P0.01)。在786-O细胞中敲低miR-222后，其靶基因DDIT4蛋白的表达显著上调，过表达miR-222后，DDIT4表达明显下调。荧光素酶实验结果表明，DDIT4为miR-222的直接作用靶点。RCC组织的DDIT4表达下调。在786-O细胞中抑制miR-222表达后，LC3-Ⅱ的表达水平显著上调，自噬体数目显著增加。结论：miR-222在RCC中高表达，并可能通过靶向抑制DDIT4的表达参与调控RCC细胞自噬。

Abstract

Background and purpose: MicroRNA (miRNA

miR) plays an important regulatory role in cancer. miR-222 is reported to be up-regulated in various tumors

but its role in renal cell carcinoma (RCC) remains unclear. In this study

we detected the expression of miR-222 in both RCC and adjacent tissue samples. The aim of this study was to investigate the role of miR-222 in RCC. Methods: The expression levels of miR-222 in RCC tissue samples were quantified by quantitative real-time polymerase chain reaction (qRT-PCR). DDIT4 and LC3-Ⅱ protein expressions were determined by Western blot. Dual luciferase assay was performed to verify the target of miR-222. EGFP-LC3 microscopy assay was performed to assess autophagy. Results: Results from qRT-PCR showed that the expression of miR-222 was up-regulated in RCC tissues. Knockdown of miR-222 with specific antagomiR decreased the cell viability of 786-O cells

whereas overexpression of miR-222 increased the cell viability (P0.01). The levels of DDIT4 were upregulated in 786-O cells transfected with miR-222 antagomiR

whereas overexpression of miR-222 induced the downregulation of DDIT4 expression. Data from dual luciferase assay indicated that miR-222 directly targeted the expression of DDIT4. Consistently

the expression of DDIT4 in RCC tissues was down-regulated compared with adjacent tissues. Knockdown of miR-222 in 786-O cells induced a significant increase of autophagosome formation and LC3 lipidation. These results supported that miR-222 could inhibit autophagy in RCC cells

which may affect the clinical characteristcs of RCC. Conclusion: miR-222 is up-regulated in RCC and can inhibit the autophagy of RCC cells through downregulating the expression of DDIT4.

关键词

Keywords

references

浏览量

2280

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

端粒酶抑制剂BIBR1532联合自噬抑制剂CQ抑制黑色素瘤细胞生存的机制研究

uPAR通过MAPK信号抑制细胞自噬促进胰腺癌增殖、侵袭及化疗抵抗的作用研究

乳腺癌中心体调控蛋白SEC23B在肿瘤浸润转移中的作用及其机制研究

干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究

肾癌中调节性细胞死亡的新动向和未来展望